Healthcare Jan 31, 2023 11:02 AM (GMT+8) · EqualOcean
Fine Vision (Chinese: 仙微视觉) announced that it had raised nearly CNY 50 million in Angel Round, which was led by DingXin Capital (Chinese: 鼎心资本) and followed by Nanjing Innovation Capital Group (Chinese: 南京创投集团). Potential Capital (Chinese: 取势资本) acted as the exclusive financial adviser. Proceeds raised in this fund will be used in the R&D and industrialization of Small Incision Lenticule Extraction (SMILE) surgery equipment. Founded in 2022, Fine Vision is an ophthalmic diseases solution provider, focusing on the development and application of SMILE on ophthalmic surgery and biological material processing. Its first commercialized product, SMILE surgery equipment is expected to break the monopoly of ZEISS's Visual Max.